EHR-guided strategy reduces postop VTE eventsOctober 27, 2018TraumaDVT & Pulmonary EmbolismCardiology
Idarucizumab reversed dabigatran completely and rapidly in studyJuly 11, 2017CardiologyHematologyDVT & Pulmonary Embolism
Antithrombotics no deterrent for emergent lap appendectomyApril 26, 2017CardiologyDVT & Pulmonary Embolism
Pulmonary embolism common in patients hospitalized for syncopeOctober 19, 2016CardiologyPulmonologyDVT & Pulmonary Embolism
Algorithm for suspected pulmonary embolism safely cut CT rateOctober 3, 2016DVT & Pulmonary EmbolismImagingPulmonology
New guidelines update VTE treatment recommendationsJanuary 8, 2016CardiologyDVT & Pulmonary EmbolismHematology
Andexanet reverses anticoagulant effects of factor Xa inhibitorsNovember 16, 2015CardiologyDVT & Pulmonary Embolism
CHEST: Catheter-directed thrombolysis shows pulmonary embolism efficacyNovember 5, 2015PulmonologyCardiologyDVT & Pulmonary Embolism
Idarucizumab approved as first agent to reverse a novel oral anticoagulantOctober 16, 2015CardiologyHematologyDVT & Pulmonary Embolism
Home VTE treatment with rivaroxaban safe and effectiveJuly 22, 2015CardiologyPulmonologyHematologyDVT & Pulmonary Embolism
High VTE recurrence risk persists for at least 3 yearsJuly 9, 2015PulmonologyCardiologyHematologyDVT & Pulmonary Embolism
Extended warfarin delays return of unprovoked pulmonary embolismJuly 7, 2015PulmonologyCardiologyHematologyDVT & Pulmonary Embolism
Idarucizumab reverses dabigatran’s anticoagulant effectsJune 24, 2015DVT & Pulmonary EmbolismCardiologyTraumaHematology
